Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 8019-8028

  Moir, Susan ^a,b   Perreault, Josée ^a,b   Poulin, Louise ^a,b,c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN GP 120;

ARTICLE; CELL FUSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MODIFICATION; SYNCYTIUM; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

EID: 0029848952     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.8019-8028.1996     Document Type: Article

References (75)

1. Allan, J. S. 1991. Receptor-mediated activation of immunodeficiency viruses in viral fusion. Science 252:1322-1323.
2. Bedinger, P., A. Moriarty, R. C. von Borstel II, N. J. Donovan, K. S. Steimer, and D. Littman. 1988. Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4. Nature (London) 334:162-165.
3. Benkirane, M., M. Hirn, D. Carrière, and C. Devaux. 1995. Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression hind to the immunoglobulin CDR3-like region of CD4. J. Virol. 69:6898-6902.
4. Berger, E. A., J. D. Lifson, and L. E. Eiden. 1991. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion. Proc. Natl. Acad. Sci. USA 88:8082-8086.
5. Brady, R. L., E. J. Dodson, G. G. Dodson, G. Lange, S. J. Davis, A. F. Williams, and A. N. Barclay. 1993. Crystal structure of domains 3 and 4 of rat CD4: relation to the NH2-terminal domains. Science 260:979-983.
6. Broder, C. C., and E. A. Berger. 1993. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion. J. Virol. 67:913-926.
7. Burkly, L. C., D. Olson, R. Shapiro, G. Winkler, J. J. Rosa, D. W. Thomas, C. Williams, and P. Chisholm. 1992. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion. J. Immunol. 149:1779-1787.
8. Camerini, D., and B. Seed. 1990. A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Cell 60:747-754.
9. Cao, J., L. Bergeron, E. Helseth, M. Thali, H. Repke, and J. Sodroski. 1993. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67:2747-2755.
10. Celada, F., C. Cambiaggi, J. Maccari, S. Burastero, T. Gregory, E. Patzer, J. Porter, C. McDanal, and T. Matthews. 1990. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding. J. Exp. Med. 172:1143-1150.
11. Choe, H. R., and J. Sodroski. 1992. Contribution of charged amino acids in the CDR2 region of CD4 to HIV-1 gp120 binding. J. Acquired Immune Defic. Syndr. 5:204-210.
12. Clark, S. J., W. A. Jefferies, A. N. Barclay, J. Gagnon, and A. F. Williams. 1987. Peptidc and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin-related domains. Proc. Natl. Acad. Sci. USA 84:1649-1653.
13. Clements, G. J., M. J. Price-Jones, P. E. Stephens, C. Sutton, T. F. Schulz, P. R. Clapham, J. A. McKeating, M. O. McClure, S. Thomson, M. Marsh, J. Kay, R. A. Weiss, and J. P. Moore. 1991. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res. Hum. Retroviruses 7:3-16.
14. Darveau, A., A. Pelletier, and J. Perreault. 1995. PCR-mediated synthesis of chimeric molecules. Methods Neurosci. 26:77-85.
15. Dedera, D., and L. Rainer. 1991. Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants. J. Virol. 65:6129-6136.
16. Diamond, D. C., R. Finberg, S. Chandhuri, B. P. Sleckman, and S. J. Burakoff. 1990. Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4. Proc. Natl. Acad. Sci. USA 87:5001-5005.
17. Eiden, L. E., and J. D. Lifson. 1992. HIV interactions with CD4: a continuum of conformations and consequences, Immunol. Today 13:201-206.
18. Ellens, H., and C. Larsen. 1993. CD4-induced changes in gp120/gp41 conformation and its potential relationship to fusion, p. 291-312. In J. Bentz (ed.), Viral fusion mechanisms. CRC Press. Boca Raton, Fla.
19. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
20. Fleury, S., D. Lamarre, S. Meloche, S. E. Ryu, C. Cantin, W. A. Hendrickson, and R.-P. Sekaly. 1991. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell 66:1037-1049.
21. Freed, E. O., D. J. Myers, and R. Risser. 1990. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA 87:4650-4654.
22. Fu, Y. K., T. K. Hart, Z. L. Jonak, and P. J. Bugelski. 1993. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. J. Virol. 67:3818-3825.
23. Golding, H., R. Blumenthal, J. Manischewitz, D. R. Littman, and D. S. Dimitrov. 1993. Cell fusion mediated by interaction of a hybrid CD4. CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time. J. Virol. 67:6469-6475.
24. Golding, H., D. S. Dimitrov, J. Manischewitz, C. C. Broder, J. Robinson, S. Fabian, D. R. Littman, and C. K. Lapham. 1995. Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules. J. Virol. 69:6140-6148.
25. Hammarskjöld, M.-L., J. Heimer, B. Hammarskjöld, I. Sangwan, L. Albert, and D. Rekosh. 1989. Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol. 63:1959-1966.
26. Harrison, S. C., J. Wang, Y. Yan, T. Garrett, J. Liu, U. Moebius, and E. Reinherz. 1992. Structure and interactions of CD4. Cold Spring Harbor Symp. Quant. Biol. 26:449-453.
27. Harrop, H. A., D. R. Coombe, and C. C. Rider. 1994. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding. AIDS 8:183-192.
28. Hasunuma, T., H. Tsubota, M. Watanabe, Z. W. Chen, C. I. Lord, L. C. Burkly, J. F. Daley, and N. L. Letvin. 1992. Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes. J. Immunol. 148:1841-1846.
29. Healey, D., L. Dianda J. P. Moore, J. S. McDougal, M. J. Moore, P. Estess, D. Buck, P. D. Kwong, P. C. Beverley, and Q. J. Sattentau. 1990. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J. Exp. Med. 172: 123-1242.
30. Helseth, E., U. Olshevsky, D. Gabuzda, B. Ardman, W. Haseltine, and J. Sodroski. 1990. Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion. J. Virol. 64:6314-6318.
31. Jameson, B. A., P. E. Rao, L. I. Kong, B. H. Hahn, G. M. Shaw, L. E. Hood, and S. B. H. Kent. 1988. Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science 240:1335-1339.
32. Jasin, M., K. A. Page, and D. R. Littman. 1991. Glycosylphosphatidylinositol-anchored CD4/Thy-1 chimeric molecules serve as human immunodeficiency virus receptors in human, but not mouse, cells and are modulated by gangliosides. J. Virol. 65:440-444.
33. Johansen, T. E., M. S. Scholler, S. Tolstoy, and T. W. Schwartz. 1990. Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors. FEBS Lett. 267:289-294.
34. Kang, C. Y., K. Hariharan, M. R. Posner, and P. Nara. 1993. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120. J. Immunol. 151:449-457.
35. Klasse, P. J., and J. P. Moore. 1992. Kinetics of the HIV-CD4 interactions and virus-cell fusion. AIDS 6:325-327.
36. Konopka, K., E. Pretzer, F. Celada, and N. Duzgunes. 1995. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity. J. Gen. Virol. 76:669-679.
37. Kost, T. A., J. A. Kessler, I. R. Patel, J. G. Gray, L. K. Overton, and S. G. Carter. 1991. Human immunodeficiency virus infection and syncytium formation in HeLa cells expressing glycophospholipid-anchored CD4. J. Virol. 65:3276-3283.
38. Kwong, P. D., S. E. Ryu, W. A. Hendrikson, R. Axel, R. M. Sweet, G. Folena-Wasserman, P. Hensley, and R. W. Sweet. 1990. Molecular characteristics of recombinant human CD4 as deduced from polymorphic crystals. Proc. Natl. Acad. Sci. USA 87:6423-6427.
39. Lange, G., S. J. Lewis, G. N. Murshudov, G. G. Dodson, P. C. Moody, J. P. Turkenburg, A. N. Barclay, and R. L. Brady. 1994. Crystal structure of an extracellular fragment of the rat CD4 receptor containing domains 3 and 4. Structure 2:469-481.
40. Langedijk, J. P., W. C. Puijk, W. van Hoorn, and R. H. Meloen. 1993. Location of CD4 dimerization site explains critical role of CDR3-like region in HIV-1 infection and T-cell activation and implies a model for complex of coreceptor-MHC. J. Biol. Chem. 268:16875-16878.
41. Lasky, L. A., G. Nakamura, D. H. Smith, C. Fennier, C. Shimasaki, E. Patzer, P. Berman, T. Gregory, and D. J. Capon. 1987. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975-985.
42. Lazaro, I., D. Naniche, N. Signoret, A. M. Bernard, D. Marguet, D. Klatzmann, T. Dragic, M. Alizon, and Q. Sattentau. 1994. Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26. J. Virol. 68:6535-6546.
43. Lifson, J. D., G. R. Reyes, M. S. McGrath, S. B. Stein, and E. G. Engleman. 1986. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science 232:1123-1127.
44. Maddon, P. J., D. R. Littman, M. Godfrey, D. E. Maddon, L. Chess, and R. Axel. 1985. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell 42:93-104.
45. Marshall, W. L., E. S. Mittler, P. Avery, J. P. Lawrence, and R. W. Finberg. 1994. Glycosylphosphatidylinositol-anchored CD4 supports human immunodeficiency virus type 1 replication, but not cytopathic effect, in T-cell transfectants. J. Virol. 68:4039-4042.
46. Matthews, T. J., C. Wild, C. H. Chen, D. P. Bolognesi, and M. L. Greenberg. 1994. Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol. Rev. 140:93-104.
47. McKeating, J, A., J. Cordell, C. J. Dean, and P. Balfe. 1992. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120. Virology 191:732-742.
48. Moebius, U., L. K. Clayton, S. Abraham, S. C. Harrison, and E. L. Reinherz. 1992. The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure. J. Exp. Med. 176:507-517.
49. Moir, S., and L. Poulin. 1996. Expression of HIV-1 env gene in a human T-cell line for a rapid and quantifiable fusion assay. AIDS Res. Hum. Retroviruses 12:811-820.
50. Moir, S., and L. Poulin. Unpublished observations.
51. Moore, J. P. 1991. Model for receptor mediated activation of immunodeficiency viruses in viral fusion. Science 252:1322-1323.
52. Moore, J. P. 1993. A monoclonal antibody to the CDR-3 region of CD4 inhibits soluble CD4 binding to virions of human immunodeficiency virus type 1. J. Virol. 67:3656-3659.
53. Moore, J. P., and P. L. Nara. 1991. The role of the V3 loop of gp120 in HIV infection. AIDS 5:S21-S33.
54. + cells. J. Virol. 66:4784-4793.
55. Pantaleo, G., G. Poli, L. Butini, C. Fox, A. I. Dayton, and A. S. Fauci. 1991. Dissociation between syncytia formation and HIV spreading. Suppression of syncytia formation does not necessarily reflect inhibition of HIV infection. Eur. J. Immunol. 21:1771-1774.
56. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
57. Pleskoff, O., M. Seman, and M. Alizon. 1995. Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion. J. Virol. 69:570-574.
58. Poulin, L., L. A. Evans, S. B. Tang, A. Barboza, H. Legg, D. R. Littman, and J. A. Levy. 1991. Several CD4 domains can play a role in human immunodeficiency virus infection in cells. J. Virol. 65:4893-4901.
59. Ryu, S. E., P. D. Kwong, A. Truneh, T. G. Porter, J. Arthos, M. Rosenberg, X. P. Dai, N. H. Xuong, R. Axel, R. W. Sweet, and W. A. Hendrickson. 1990. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature (London) 348:419-426.
60. Ryu, S. E., A. Truneh, R. W. Sweet, and W. A. Hendrickson. 1994. Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices. Structure 2:59-74.
61. Sattentau, Q. J. 1992. CD4 activation of HIV fusion. Int. J. Cell Cloning 10:323-332.
62. Sattentau, Q. J., A. G. Dalgleish, R. A. Weiss, and P. C. L. Beverly. 1986. Epitopes of the CD4 antigen and HIV infection. Science 234:1120-1123.
63. Sattentau, Q. J., and J. P. Moore. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407-415.
64. Sattentau, Q. J., and J. P. Moore. 1993. The role of CD4 in HIV binding and entry. Philos. Trans. R. Soc. Lond. B 342:59-66.
65. Sattenlau, Q. J., J. P. Moore, F. Vignaux, F. Traincard, and P. Poignard. 1993. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67:7383-7393.
66. Simmons, G., A. McKnight, Y. Takeuchi, H. Hoshino, and P. R. Clapham. 1995. Cell-to-cell fusion, but not virus entry in macrophages by T-cell line tropic HIV-1 strains: a V3 loop-determined restriction. Virology 209:696-700.
67. Sodroski, J., W. C. Goh, C. Rosen, K. Campbell, and W. A. Haseltine. 1986. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (London) 322:470-474.
68. Stein, B. S., S. D. Gowda, J. D. Lifson, R. C. Penhallow, K. G. Bensch, and E. G. Engleman. 1987. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49:659-668.
69. Szabo, G. J., P. S. Pine, J. L. Weaver, P. E. Rao, and A. Aszalos. 1992. CD4 changes conformation upon ligand binding. J. Immunol. 149:3596-3604.
70. Tendian, S. W., D. G. Myszka, R. W. Sweet, I. M. Chaiken, and C. G. Brouillette. 1995. Interdomain communication of T-cell CD4 studied by absorbance and fluorescence difference spectroscopy measurements of urea-induced unfolding. Biochemistry 34:6464-6474.
71. Thali, M., J. P. Moore, C. Furman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski. 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:3978-3988.
72. Truneh, A., D. Buck, D. R. Cassatt, R. Juszezak, S. Kassis, S. E. Ryu, D. Healey, R. Sweet, and Q. Sattentau. 1991. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J. Biol. Chem. 266:5942-5948.
73. Tsui, P., R. W. Sweet, G. Sathe, and M. Rosenberg. 1992. An efficient phage plaque screen for the random mutational analysis of the interaction of HIV-1 gp120 with human CD4. J. Biol. Chem. 267:9361-9367.
74. Walker, L., D. Wilks, J. O'Brien, J. Habeshaw, and A. Dalgleish. 1992. Localized conformational changes in the N-terminal domain of CD4 identified in competitive binding assay of monoclonal antibodies and HIV-1 envelope glycoprotein. AIDS Res. Hum. Retroviruses 8:1083-1090.
75. Wang, J., Y. Yan, T. P. J. Garrett, J. Liu, D. W. Rodgers, R. L. Garlick, G. E. Tarr, Y. Husain, E. L. Reinherz, and S. C. Harrison. 1990. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature (London) 348:411-418.